Latest News & Features
Americas
The system governing access to genetic resources in Brazil has been strengthened by a recent legal update, explain Andrea Granthon and Tatiana Schuenck of Luiz Leonardos & Advogados. 9 June 2016
Asia
An Indian company is working on two approaches to creating a vaccine for the Zika virus, while several trademark applications have been filed for the term. Lucy Rana
of SS Rana reports. 8 June 2016
Africa
Africa Harvest is working towards reducing hunger and poverty in some of the world’s poorest countries. Dr Florence Wambugu, founder of the organisation, tells LSIPR more about its work. 8 June 2016
Americas
Aided by strong patent protection, efforts are continuing in Brazil to develop a vaccine against the notorious dengue fever. Gabriel Di Blasi of Di Blasi, Parente & Associados and Jorge Kalil of the Instituto Butantan explain more. 8 June 2016
Americas
There are several rules to watch out for when seeking patent protection for antibodies in Brazil, as Kene Gallois of Daniel Advogados reports. 8 June 2016
Americas
Merial, which is well-known for making products that kill fleas and ticks on cats and dogs, faces a number of challenges on the IP front, as global head of IP Dr Judy Jarecki-Black, tells LSIPR. 7 June 2016
Big Pharma
EPO case law suggests that inventions covering homeopathic medicines do not have to meet a higher bar of patentability than conventional medicaments, but it still must be shown that the claimed products lead to the alleged therapeutic effect. André Guder of Uexküll & Stolberg reports. 7 June 2016
Americas
Applicants wishing to extend their patents’ term of protection do not have to necessarily match up the wording of the claims and the label of the relevant drug for there to be infringement by an ANDA, as MaryAnne Armstrong of Birch, Stewart, Kolasch & Birch reports. 7 June 2016
Big Pharma
Europe is not providing an adequate level of patent protection to the medical device industry, and while a solution exists, legislators need to be brave enough to abandon convention and adopt it, argue Reuben Jacob and Fiona Kellas of Jenkins. 6 June 2016
Asia
Over the past few years there have been a number of IP developments in the pharma and biotech industries in Japan, including on patent term extension and product-by-process claims. Osamu Yamamoto of Yuasa and Hara provides a roundup. 6 June 2016